US Patent Issued to Memorial Sloan Kettering Cancer Center on Nov. 18 for "Small molecule inhibitors of ULK1" (New York Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,284, issued on Nov. 18, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Small molecule inhibitors of ULK1" was invented by Xuejun Jiang (New York), Derek Tan (New York), Deguang Liang (New York), Pui-Mun Wong (New York) and Takao Suzuki (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology is directed to compounds, compositions, and methods related to inhibition of ULK1 and treatment of cancers therefrom."

The patent was filed on Dec. 29, 2020, under Application No. 17/790,091.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P...